Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Anna Khomenya (Omsk, Russian Federation), Anna Khomenya, Maria Vershinina, Galina Nechaeva, Lev Grinberg. Marfanoid phenotype as a predictor of COPD formation in young patients. Eur Respir J 2015; 46: Suppl. 59, 3008

Member's Comments

No comment yet.

Related content which might interest you: Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype Source: Annual Congress 2013 –COPD treatment Year: 2013 The distribution of phenotypes in a population of severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Characterization and functional progression of COPD in young adults (early COPD) Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Prevalence and characteristics of the asthma-COPD overlap syndrome - or the asthma-like COPD phenotype - in a COPD high risk population Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Cardiovascular status of patients with a severe form of COPD Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 The most frequent comorbidies in COPD and their inflence on the prognosis of the disease Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Sarcopenia in Japanese patients with COPD: prevalence, relationship with COPD severity. Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 COPDCoRi, an algorithm for predicting the risk of coronaropathy in COPD patients Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 Hypogonadism as a factor influencing health condition in COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Risk factors for new-onset asthma and early COPD in a cohort of young adults Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Metabolic syndrome in patients with COPD and their association with systemic inflammation Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Renal impairment a neglected comorbidity in patients with COPD Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort Source: International Congress 2015 – Multidimensional analysis of respiratory problems Year: 2015 High prevalence of altered cardiac repolarization in patients with COPD Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease Year: 2013 The role of COPD in development of osteoporosis Source: International Congress 2014 – Markers Year: 2014 Lung function in never smoking patients with alpha1antitrypsin deficiency Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 The decrease of nutritional status and increasing of the risk of osteoporotic fractures in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD biomarkers Year: 2013